Molecular analysis of the pathophysiology basis of nephrotic syndrome
Molecular analysis of the pathophysiology basis of nephrotic syndrome
批准号:
23591586
负责人:
SEKINE Takashi
金额:
$3.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013
中文摘要
为了阐明肾病综合征,尤其是FSGS的病理生理机制,我们对肌球蛋白IIA进行了研究。首先,我们确定了肌球蛋白IIA的精确定位;肌球蛋白IIA位于足眼的初级突起和细胞体。在大量蛋白尿的人类肾脏疾病中,只有FSGS患者的肾脏标本中肌球蛋白IIA的表达水平降低,而其他肾脏疾病患者的肾脏标本中肌球蛋白IIA的表达水平没有变化。在大鼠PAN肾病模型中,当出现大量蛋白尿时,第11天肌球蛋白IIA的表达水平降低。综上所述,肌球蛋白IIA在人类特发性肾病综合征,尤其是FSGS的发生发展中起着非常重要的作用。
英文摘要
To lucidate the pathophysiology of nephrotic syndrome, especially FSGS, we investigated myosin IIA. First, We determined the precise localization of myosin IIA; myosin IIA is located at the primary process and cell body of podocye. In human kidney diseases manifesting heavy proteinuria, only in the kidney specimen from the patients with FSGS, the level of expression o myosin IIA was decreased, while in those from other kidney disease patients were not changed. In rat PAN nephrosis model, the expression level of myosin IIA was decreased at day 11 when heavy proteinuria was observed. Taken together, myosin IIA play the very important role in the development of human idiopathic nephrotic syndrome, especially FSGS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The long-term use of enalapril and hydrochlorothiazide in two novel mutations patients with Dent's disease type 1.
两名新突变 1 型 Dent 病患者长期使用依那普利和氢氯噻嗪。
DOI:
--
发表时间:
2012
期刊:
J Bras Nefrol.
影响因子:
--
作者:
[Vaisbich MH, Henriques Ldos S, Igarashi T, Sekine T, Seki G, Koch VH.]
通讯作者:
Koch VH.
V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlights protean agonism of V2R antagonists.
部分肾性尿崩症中的 V2 加压素受体 (V2R) 突变凸显了 V2R 拮抗剂的多样化激动作用。
DOI:
--
发表时间:
2012
期刊:
J Biol Chem
影响因子:
4.8
作者:
[Takahashi K, Makita N, Manaka K, Hisano M, Akioka Y, Miura K, Takubo N, Iida A, Ueda N, Hashimoto M, Fujita T, Igarashi T, Sekine T, Iiri T]
通讯作者:
Iiri T
V2R mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists
部分肾性尿崩症中的 V2R 突变凸显了 V2R 拮抗剂的多样化激动作用
DOI:
10.1074/jbc.m111.268797
发表时间:
2012
期刊:
J.Biol.Chem
影响因子:
--
作者:
[Takahashi K, Makita N, et al.]
通讯作者:
et al.
DOI:
10.1091/mbc.e10-12-0929
发表时间:
2011-06-01
期刊:
Molecular biology of the cell
影响因子:
3.3
作者:
[Kanda S, Harita Y, Shibagaki Y, Sekine T, Igarashi T, Inoue T, Hattori S]
通讯作者:
Hattori S
ネフローゼ症候群の関連分子とpodocyte細胞骨格—Epstein症候群から学ぶ
肾病综合征相关分子及足细胞骨架——向爱泼斯坦综合征学习
DOI:
--
发表时间:
2013
期刊:
日本小児科学会雑誌
影响因子:
--
作者:
[Imuta N, Yoshiie K, Matayoshi S, Nishi J, 浜武継,中西浩一,向山弘展,戸川寛子,島友子,宮嶋正康,高橋久英,長尾枝澄香,飯島一誠,吉川徳茂, 関根孝司]
通讯作者:
関根孝司
共 11 条
Marketing Development of Home Electric Appliance in Japan, China, and Korea:from Viewpoint of Advantageous Position Dynamics
-
批准号:22330132
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.66万
-
财政年份:2010
-
负责人:SEKINE Takashi
-
依托单位:
Analysis of phosphorylation cascade of molecules expressed in podocyte as the pathophysiological basis of kidney diseases
-
批准号:20591271
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:SEKINE Takashi
-
依托单位:
Identification of molecules responsible for the development of nephritic syndrome
-
批准号:18591183
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.44万
-
财政年份:2006
-
负责人:SEKINE Takashi
-
依托单位:
Molecular analysis of the gene responsible for the hereditary disorders of urate transport with impairment of renal function
-
批准号:15591089
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2003
-
负责人:SEKINE Takashi
-
依托单位:
Genetic analysis of transporters and channels related to urolithiasis or hydronephrosis
-
批准号:13671101
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:SEKINE Takashi
-
依托单位:
The study toward the development of specific agonist and antagonist for the purinergic receptors in the kidney
-
批准号:08672623
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:SEKINE Takashi
-
依托单位:
国内基金
海外基金
Myosin IIa信号轴介导内皮与免疫细胞互作调控血管保护的作用与机制
-
批准号:31911530147
-
项目类别:重点项目
-
资助金额:297万元
-
批准年份:2019
-
负责人:罗金才
-
依托单位:
Myosin IIa信号轴介导内皮与免疫细胞互作调控血管保护的作用与机制
-
批准号:81930011
-
项目类别:重点项目
-
资助金额:297.0万元
-
批准年份:2019
-
负责人:罗金才
-
依托单位: